Abnormalities of the Immune System in Cancer Patients

แชร์
ฝัง
  • เผยแพร่เมื่อ 6 ก.พ. 2025

ความคิดเห็น • 8

  • @soniiaa15
    @soniiaa15 2 ปีที่แล้ว

    So extremely helpful and insightful. Thank you so much, Dr. Mustafa and LLS!

  • @Msunrose
    @Msunrose 3 ปีที่แล้ว +1

    Excellent presentation! Thank you very much.

  • @paulinoregon7538
    @paulinoregon7538 3 ปีที่แล้ว +2

    thank you......

  • @PsdAnchorsAway
    @PsdAnchorsAway 3 ปีที่แล้ว +1

    Thank you for perfectly sharing what lots of people do not understand.

  • @saliunofisat3142
    @saliunofisat3142 2 ปีที่แล้ว +1

    Thank you for doing a great job and cured me of my cancer virus completely, you are super authentic #Drobulor I really appreciate you for all you have done. keep saving lives doc❤️

  • @kathibeiswenger9580
    @kathibeiswenger9580 3 ปีที่แล้ว

    What about people with FL 10 years out from therapy or DLBCL 3 years out from therapy? Are they still considered at risk if they were given Bendamustine/Rituximab or R-CHOP? What about the patient who had FL and also common variable immunodeficiency?

  • @saliunofisat3142
    @saliunofisat3142 2 ปีที่แล้ว +1

    Thank you for doing a great job and cured me of my cancer virus completely, you are super authentic #Drobulor I really appreciate you for all you have done. keep saving lives doc❤️